Evidence map›Paper›PMID 27473358›Full record

ArticleBMC complementary and alternative medicine2016

Protective effect of fermented Cyclopia intermedia against UVB-induced damage in HaCaT human keratinocytes.

A-Rang Im, Sung Hum Yeon, Jung Seung Lee, Key An Um, Young-Joon Ahn, Sungwook Chae

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. In Vitro Anti-Inflammatory and Skin Protective Effects ofJournal of microbiology and biotechnology · 2024
    Article
  4. Article
  5. Article
  6. Marine drugs · 2021
    Article
  7. The Protective Effect ofPlants (Basel, Switzerland) · 2021
    Article
  8. Article
  9. Skin Hydration Effects of Scale-Up FermentedEvidence-based complementary and alternative medicine : eCAM · 2020
    Article
  10. Article
  11. BioMed research international · 2017
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

A-Rang ImKM Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon, 305-811, Republic of Korea.
Sung Hum YeonBiomodulation Major. Department of Agricultural Biotechnology, Seoul National University, Seoul, 157-742, Republic of Korea.
Jung Seung LeeResearch Center, Huons Co. Ltd, 55 Hanyangdaehak-ro, Sangrok-gu, Ansan, Gyeonggi-do, 426-791, Republic of Korea.
Key An UmResearch Center, Huons Co. Ltd, 55 Hanyangdaehak-ro, Sangrok-gu, Ansan, Gyeonggi-do, 426-791, Republic of Korea.
Young-Joon AhnBiomodulation Major. Department of Agricultural Biotechnology, Seoul National University, Seoul, 157-742, Republic of Korea. yjahn@snu.ac.kr.
Sungwook ChaeKM Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon, 305-811, Republic of Korea. kendall@kiom.re.kr.
Huons (South Korea) · KRKorea Institute of Oriental Medicine · KRSeoul National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe fermented leaves and stems of Cyclopia intermedia are used to brew honeybush tea, a herbal tea indigenous to South Africa. The aim of this study was to evaluate the protective effect of fermented honeybush extracts (FH ex) and scale-up fermented honeybush extracts (SFH ex) against ultraviolet B (UVB)-induced damage in HaCaT keratinocytes. To this end, we examined UVB-induced cell viability, antioxidant enzymes, and inflammatory mediators in HaCaT cells.

methodsUVB significantly decreased HaCaT cell viability, whereas FH ex and SFH ex did not exhibit cytotoxic effects and increased the viability of the HaCaT cells. To further investigate the protective effects of FH ex on UVB-induced oxidative stress in HaCaT cells, the activities of superoxide dismutase (SOD), catalase (CAT), matrix metalloproteinases (MMPs), pro-inflammatory cytokines and skin barrier function in terms of involucrin, filaggrin, and loricrin were analyzed.

resultsUVB-induced treatment reduced the activity of antioxidant enzymes and skin barrier function, while FH ex or SFH ex increased their activity. These results suggest that FH ex exerted cytoprotective activity against UVB-induced oxidative stress in HaCaT cells through stimulation of antioxidant enzymes activities. Furthermore, FH ex and SFH ex suppressed the UVB-induced expression of inflammatory mediators, such as IL-1β, IL-6, and IL-8, at mRNA level together with down regulation of matrix metalloproteinase (MMPs). In addition, FH ex and SFH ex reversed the phosphorylation of mitogen-activated protein kinase (MAPK) induced by UVB-irradiation. Notably, FH ex and SFH ex markedly inhibited UVB-induced activation of ERK, p38, and JNK. Thus, this agent exhibits anti-oxidative and -inflammatory effects via lowering ROS production, suppressing p38, ERK, and JNK activation, and down-regulating expression of MMPs.

conclusionsThese findings suggest that FH ex and SFH ex can be used as a skin anti-photoaging agent.

Indexed as

Cell SurvivalKeratinocytesCell LineFabaceaeFilaggrin ProteinsHumansMatrix MetalloproteinasesMitogen-Activated Protein KinasesPlant ExtractsProtective AgentsUltraviolet RaysFilaggrin ProteinsFLG protein, humanMatrix MetalloproteinasesMitogen-Activated Protein KinasesPlant ExtractsProtective AgentsFermented honeybush extractsHaCaT keratinocytesMatrix metalloproteinase (MMP)Mitogen-activated protein kinase (MAPK)Reactive oxygen species (ROS)Scale-up fermented honeybush extracts

Identifiers

PMID27473358
PMCPMC4966866
OpenAlexW2503700669

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.